Stocks Finish with Gains

The Dow reached a three and one-half year high as drug stocks rebounded, while techs were boosted by an analyst upgrade of Intel

Stocks ended with solid gains Tuesday, with blue chips reaching theirhighest levels since 2001 amid moderate trading volumes, strong quarterly earnings results from investment banks, and an uptick in pharma stocks. Bets on the market's strength in the second half of December largely drove direction Tuesday, says S&P MarketScope.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.